US Customs moves on Canadian drugs

13 March 2006

After admitting that it had increased enforcement of a federal law banning personal importation of medicine, the US Customs and Border Protection has begun releasing packages of seized medication to consumers. Federal authorities had generally allowed shipments from licensed Canadian pharmacies, but the recent action saw about 5% of orders from the USA seized over a period of several months.

The Customs' crackdown had prompted seniors and Congress to ask why the action was being taken when Food and Drug Administration policy allows a 90-day supply to be mail-ordered or hand-carried across the border, if purchased from a licensed Canadian pharmacy.

Some senators questioned whether the action was taken to prompt seniors to enroll in the new Medicare drug program, with Senator Bill Nelson noting that the seizures began two days after enrollment in the program opened. 11 members of Congress have written to the FDA to complain about the seizures. Customs officials have denied the allegations that the seizures were linked to enrollment in the drug plan.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight